Indole Hallucinogens as Animal Models of Schizophrenia
Animal Models in Human Psychobiology January 1, 1976 Edward F. Domino 3 citations
Research on indole hallucinogens and schizophrenia is hampered by a persistent divide: clinicians with access to schizophrenic patients lack advanced gas chromatographic and mass spectrographic facilities, while chemists with those tools cannot access suitable patient populations. Psychiatric research strategy, funding, and social and legal pressures around informed consent and commitment of the mentally ill further slow progress. In Michigan, these obstacles have become so severe that most research with mental patients has stopped. The authors argue that efforts to protect patients' rights are inadvertently discarding their rights to proper diagnoses and better treatments.